Mackenzie Financial Corp Has $610,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Mackenzie Financial Corp grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 97.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,819 shares of the company's stock after acquiring an additional 4,348 shares during the period. Mackenzie Financial Corp's holdings in Henry Schein were worth $610,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Forum Financial Management LP acquired a new position in Henry Schein during the 4th quarter worth $221,000. Toronto Dominion Bank lifted its position in shares of Henry Schein by 6.7% during the fourth quarter. Toronto Dominion Bank now owns 66,997 shares of the company's stock worth $4,636,000 after purchasing an additional 4,218 shares during the last quarter. GF Fund Management CO. LTD. acquired a new position in Henry Schein in the fourth quarter worth about $194,000. Investment Management Corp VA ADV acquired a new position in Henry Schein in the fourth quarter worth about $32,000. Finally, Ananym Capital Management LP bought a new stake in Henry Schein in the fourth quarter valued at about $32,628,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

Shares of HSIC traded down $0.18 during trading hours on Wednesday, reaching $70.39. 1,210,614 shares of the company's stock traded hands, compared to its average volume of 1,679,208. The firm has a market capitalization of $8.57 billion, a price-to-earnings ratio of 28.97, a P/E/G ratio of 2.13 and a beta of 0.87. The business's fifty day simple moving average is $67.67 and its two-hundred day simple moving average is $71.69. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue was down .1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.10 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analysts Set New Price Targets

HSIC has been the subject of several research reports. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Barrington Research decreased their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Piper Sandler lowered their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $79.30.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.